{
     "PMID": "26792005",
     "OWN": "NLM",
     "STAT": "MEDLINE",
     "DCOM": "20171013",
     "LR": "20180102",
     "IS": "1863-2661 (Electronic) 1863-2653 (Linking)",
     "VI": "221",
     "IP": "9",
     "DP": "2016 Dec",
     "TI": "Galanin (1-15) enhances the antidepressant effects of the 5-HT1A receptor agonist 8-OH-DPAT: involvement of the raphe-hippocampal 5-HT neuron system.",
     "PG": "4491-4504",
     "AB": "Galanin N-terminal fragment (1-15) [GAL(1-15)] is associated with depression-related and anxiogenic-like effects in rats. In this study, we analyzed the ability of GAL(1-15) to modulate 5-HT1A receptors (5-HT1AR), a key receptor in depression. GAL(1-15) enhanced the antidepressant effects induced by the 5-HT1AR agonist 8-OH-DPAT in the forced swimming test. These effects were stronger than the ones induced by Galanin (GAL). This action involved interactions at receptor level since GAL(1-15) affected the binding characteristics and the mRNA levels of 5-HT1AR in the dorsal hippocampus and dorsal raphe. The involvement of the GALR2 was demonstrated with the GALR2 antagonist M871. Proximity ligation assay experiments indicated that 5-HT1AR are in close proximity with GALR1 and GALR2 in both regions and in raphe RN33B cells. The current results indicate that GAL(1-15) enhances the antidepressant effects induced by 8-OH-DPAT acting on 5-HT1AR operating as postjunctional or as autoreceptors. These results may give the basis for the development of drugs targeting potential GALR1-GALR2-5-HT1AR heteroreceptor complexes linked to the raphe-hippocampal 5-HT neurons for the treatment of depression.",
     "FAU": [
          "Millon, Carmelo",
          "Flores-Burgess, Antonio",
          "Narvaez, Manuel",
          "Borroto-Escuela, Dasiel O",
          "Santin, Luis",
          "Gago, Belen",
          "Narvaez, Jose Angel",
          "Fuxe, Kjell",
          "Diaz-Cabiale, Zaida"
     ],
     "AU": [
          "Millon C",
          "Flores-Burgess A",
          "Narvaez M",
          "Borroto-Escuela DO",
          "Santin L",
          "Gago B",
          "Narvaez JA",
          "Fuxe K",
          "Diaz-Cabiale Z"
     ],
     "AD": "Universidad de Malaga, Instituto de Investigacion Biomedica de Malaga, Facultad de Medicina, Departamento de Fisiologia, Campus de Teatinos s/n, 29071, Malaga, Spain. Universidad de Malaga, Instituto de Investigacion Biomedica de Malaga, Facultad de Medicina, Departamento de Fisiologia, Campus de Teatinos s/n, 29071, Malaga, Spain. Universidad de Malaga, Instituto de Investigacion Biomedica de Malaga, Facultad de Medicina, Departamento de Fisiologia, Campus de Teatinos s/n, 29071, Malaga, Spain. Department of Neuroscience, Karolinska Institute, Stockholm, Sweden. Universidad de Malaga, Instituto de Investigacion Biomedica de Malaga, Facultad de Psicologia, Departamento de Psicobiologia, Campus de Teatinos s/n, 29071, Malaga, Spain. Universidad de Malaga, Instituto de Investigacion Biomedica de Malaga, Facultad de Medicina, Departamento de Fisiologia, Campus de Teatinos s/n, 29071, Malaga, Spain. Universidad de Malaga, Instituto de Investigacion Biomedica de Malaga, Facultad de Medicina, Departamento de Fisiologia, Campus de Teatinos s/n, 29071, Malaga, Spain. Department of Neuroscience, Karolinska Institute, Stockholm, Sweden. Universidad de Malaga, Instituto de Investigacion Biomedica de Malaga, Facultad de Medicina, Departamento de Fisiologia, Campus de Teatinos s/n, 29071, Malaga, Spain. zaida@uma.es.",
     "LA": [
          "eng"
     ],
     "PT": [
          "Journal Article",
          "Research Support, Non-U.S. Gov't"
     ],
     "DEP": "20160120",
     "PL": "Germany",
     "TA": "Brain Struct Funct",
     "JT": "Brain structure & function",
     "JID": "101282001",
     "RN": [
          "0 (Antidepressive Agents)",
          "0 (M871 peptide)",
          "0 (Peptide Fragments)",
          "0 (Peptides)",
          "0 (RNA, Messenger)",
          "0 (Receptor, Galanin, Type 1)",
          "0 (Receptor, Galanin, Type 2)",
          "0 (Serotonin Receptor Agonists)",
          "112747-70-3 (galanin (1-15))",
          "78950-78-4 (8-Hydroxy-2-(di-n-propylamino)tetralin)",
          "88813-36-9 (Galanin)"
     ],
     "SB": "IM",
     "MH": [
          "8-Hydroxy-2-(di-n-propylamino)tetralin/*administration & dosage/pharmacology",
          "Animals",
          "Antidepressive Agents/*administration & dosage/pharmacology",
          "Behavior, Animal/drug effects/physiology",
          "Dorsal Raphe Nucleus/*drug effects/metabolism",
          "Galanin/*administration & dosage/pharmacology",
          "Hippocampus/*drug effects/metabolism",
          "Male",
          "Peptide Fragments/*administration & dosage/pharmacology",
          "Peptides/administration & dosage",
          "RNA, Messenger/metabolism",
          "Rats",
          "Rats, Sprague-Dawley",
          "Receptor, Galanin, Type 1/metabolism",
          "Receptor, Galanin, Type 2/antagonists & inhibitors/metabolism",
          "Serotonergic Neurons/*drug effects/metabolism",
          "Serotonin Receptor Agonists/*administration & dosage/pharmacology"
     ],
     "OTO": [
          "NOTNLM"
     ],
     "OT": [
          "*5-HT1A receptors",
          "*Depression",
          "*Galanin",
          "*Galanin (1-15)",
          "*Heteroreceptor complexes"
     ],
     "EDAT": "2016/01/23 06:00",
     "MHDA": "2017/10/14 06:00",
     "CRDT": [
          "2016/01/22 06:00"
     ],
     "PHST": [
          "2015/09/07 00:00 [received]",
          "2015/12/23 00:00 [accepted]",
          "2016/01/23 06:00 [pubmed]",
          "2017/10/14 06:00 [medline]",
          "2016/01/22 06:00 [entrez]"
     ],
     "AID": [
          "10.1007/s00429-015-1180-y [doi]",
          "10.1007/s00429-015-1180-y [pii]"
     ],
     "PST": "ppublish",
     "SO": "Brain Struct Funct. 2016 Dec;221(9):4491-4504. doi: 10.1007/s00429-015-1180-y. Epub 2016 Jan 20.",
     "term": "hippocampus"
}